| Primary |
| Parkinson's Disease |
75.0% |
| Epilepsy |
25.0% |
|
|
| Secondary |
| Parkinson's Disease |
68.9% |
| Product Used For Unknown Indication |
9.0% |
| Drug Use For Unknown Indication |
6.9% |
| Hypertension |
2.3% |
| Anxiety |
1.9% |
| Pain |
1.5% |
| Memory Impairment |
1.3% |
| Type 2 Diabetes Mellitus |
1.0% |
| Depression |
0.9% |
| Epilepsy |
0.8% |
| Parkinsonism |
0.8% |
| Pyrexia |
0.7% |
| Orthostatic Hypotension |
0.6% |
| Dementia |
0.6% |
| Diabetes Mellitus |
0.5% |
| Insomnia |
0.5% |
| Agitation |
0.5% |
| Cardiac Failure |
0.5% |
| Hallucination |
0.5% |
| Abnormal Behaviour |
0.4% |
|
| Chromaturia |
10.8% |
| Depression |
10.8% |
| Dyspnoea |
10.8% |
| Irritability |
10.8% |
| Muscle Spasms |
10.8% |
| Amimia |
7.8% |
| Compulsive Shopping |
5.8% |
| Back Pain |
4.3% |
| Legal Problem |
4.3% |
| Escherichia Urinary Tract Infection |
4.0% |
| Crying |
2.8% |
| Pyrexia |
2.5% |
| Somnolence |
2.3% |
| Thrombocytopenia |
2.3% |
| Orthostatic Hypotension |
2.0% |
| Tremor |
2.0% |
| Hypotonia |
1.8% |
| Cerebral Haematoma |
1.5% |
| Delirium |
1.5% |
| Dysphagia |
1.5% |
|
| Concomitant |
| Parkinson's Disease |
34.8% |
| Product Used For Unknown Indication |
17.6% |
| Drug Use For Unknown Indication |
16.6% |
| Hypertension |
5.4% |
| Depression |
4.1% |
| Parkinsonism |
2.7% |
| Bronchitis |
2.2% |
| Atrial Fibrillation |
2.1% |
| Osteoporosis |
1.6% |
| Sleep Disorder |
1.6% |
| Pain |
1.5% |
| Prophylaxis |
1.5% |
| Dementia |
1.2% |
| Epilepsy |
1.1% |
| Anxiety |
1.0% |
| Chronic Obstructive Pulmonary Disease |
1.0% |
| Thrombosis Prophylaxis |
1.0% |
| Type 2 Diabetes Mellitus |
1.0% |
| Agitation |
0.9% |
| Arrhythmia |
0.9% |
|
| Vomiting |
8.5% |
| Malaise |
7.9% |
| Thrombocytopenia |
7.9% |
| Tremor |
6.8% |
| Fall |
5.6% |
| Hallucination |
5.6% |
| Overdose |
5.6% |
| Somnolence |
5.6% |
| Renal Failure Acute |
5.1% |
| Status Epilepticus |
5.1% |
| Eosinophilia |
4.0% |
| International Normalised Ratio Increased |
4.0% |
| Parkinson's Disease |
4.0% |
| Pathological Gambling |
4.0% |
| General Physical Health Deterioration |
3.4% |
| Parkinsonism |
3.4% |
| Pyrexia |
3.4% |
| Theft |
3.4% |
| Weight Decreased |
3.4% |
| Weight Increased |
3.4% |
|
| Interacting |
| Parkinson's Disease |
50.0% |
| Back Pain |
25.0% |
| Hypertension |
25.0% |
|
| Blood Pressure Fluctuation |
33.3% |
| Rhabdomyolysis |
33.3% |
| Myoclonus |
16.7% |
| Orthostatic Hypotension |
16.7% |
|
